Breast cancer in young women in the south of Tunisia;Le cancer du sein de la femme jeune dans le sud tunisien

Cancer/Radiotherapie

Volumn 10, Issue 8, 2006, Pages 565-571

  Khanfir, A ^a   Frikha, M ^a   Kallel, F ^a   Meziou, M ^a   Trabelsi, K ^a   Boudawara, T ^a   Mnif, J ^a   Daoud, J ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

Breast cancer; Clinical; Prognosis; Young woman

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; ANTINEOPLASTIC AGENT; CISPLATIN; CMF PROTOCOL; FEC PROTOCOL;

ADJUVANT THERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL RECORD; METASTASIS; MULTIVARIATE ANALYSIS; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; TUNISIA; UNIVARIATE ANALYSIS; ADJUVANT CHEMOTHERAPY; AGE; BREAST; BREAST TUMOR; CANCER STAGING; LYMPH NODE METASTASIS; MASTECTOMY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIOGRAPHY; SENSITIVITY AND SPECIFICITY; SURVIVAL; TIME; TREATMENT OUTCOME;

ADULT; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MASTECTOMY; METHOTREXATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; TUNISIA;

EID: 33845328020     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2006.09.115     Document Type: Article

References (31)

1. Albain K.S., Green S., and Leblanc M. Breast cancer outcome and predictors of outcome are there age differential?. J. Natl. Cancer Inst. Monogr. 16 (1994) 35-42
2. Bakkali H., Marchal C., Lesur-Schwander A., and Verhaeghe J.L. Le cancer du sein chez la femme de 30 ans et moins. Cancer Radiother. 7 (2003) 153-159
3. Bobin J.Y., Mignotte H., Catimel G., Rivoire M., Plat R., Canelo R., et al. Prognosis of operable breast cancer in women aged under forty years. Bull. Cancer 78 (1991) 819-829
4. Chan A., Pintilie M., Vallis K., Girourd C., and Goss P. Breast cancer in women ≤ 35 years: review of 1002 cases from a single institution. Ann. Oncol. 11 (2000) 1255-1262
5. Cutulli B. Cancer du sein : intérêt de l'irradiation locorégionale postopératoire après mastectomie. Presse Med. 29 (2000) 439-446
6. Diears V., Girre V., Pierga J.Y., Laurence V., Piperno-Neumann S., and Pouillart P. Actualités Docétaxel dans les cancers du sein. Bull. Cancer 91 (2004) 409-417
7. Di Leo A., Ciarlo A., Panella M., Pozzessere D., Santini S., Vinci E., et al. Controversis in the adjuvant treatment of breast cancer = the role of taxanes. Ann. Oncol. 15 (2004) 17-21 [iv]
8. Espié M., and Cottu P.H. Cancer du sein de la femme jeune : problèmes et questions. Pathol. Biol. 51 (2003) 391-392
9. Foxcroft L.M., Evans L.B., and Porter A.J. The diagnosis of breast cancer in women younger than 40. Breast 13 (2004) 297-306
10. Gajdos C., Tartter P.I., Bleiweiss I.J., Bordian C., and Brower S.T. Stage 0 to stage III breast cancer in young women. J. Am. Coll. Surg. 190 (2000) 523-529
11. Gelman K, Partridge AH, Manow M. Breast cancer in young women. ASCO 2005 congress. Educational book pp. 61-7.
12. Goldhirsch A., Glick J.H., Gelber R.D., Coates A.S., Thurlimann B., Senn H.J., et al. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann. Oncol. 16 (2005) 1569-1583
13. Grenlee R.T., Murray T., Bolden S., and Wingo P.A. Cancer statistics, 2000. CA Cancer J. Clin. 50 (2000) 7-33
14. Host H., and Lund E. Age as a prognostic factor in breast cancer. Cancer 57 (1986) 2217-2221
15. Houssami N., Irwigl L., Simpson J.M., Mckessar M., Blome S., and Noakes J. Sydney breast imaging accuracy study: comparative sensitivity and specificity of mammography and sonography in young women with symptoms. AJR Am. Roentgenol. 180 (2003) 935-940
16. Jmor S., Al-Sayer H., Heys S.D., Payne S., Miller I., Ah-See A., et al. Breast cancer in women aged 35 years and under: prognosis and survival. J. R. Coll. Surg. Edinb. 47 (2002) 693-699
17. Kothari A.S. Breast carcinoma in women aged 25 years or less. Cancer 94 (2002) 606-614
18. Krainer M., Silva-Arrieta S., Fitzgerald M.G., Shimada A., Ishioka C., Kanamaru R., et al. Differential contributions of BRCA1 and BRCA2 to early -onset breast cancer. N. Engl. J. Med. 336 (1997) 1448-1449
19. Kroman N., Jensen M.B., Wohlfahrt J., Mouridsen H.T., Andersen P.K., and Melbye M. Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ 320 (2000) 474-478
20. Kurtz J.M., Amalric R., Brandone H., Ayme Y., Jacquemier J., Pietra J.C., et al. Local recurrence after breast conserving-surgery and radiotherapy. Frequency, time course and prognosis. Cancer 63 (1989) 1912-1917
21. Le Monique G., and Flamant R. Le cancer du sein chez la femme jeune : données épidémiologiques. Pathol. Biol. 39 (1992) 837-838
22. Maalej M., Frikha H., Ben Salem S., Daoud J., Bouaouina N., Ben Abdallah M., et al. Le cancer du sein en Tunisie : étude clinique et épidémiologique. Bull. Cancer 86 (1999) 302-306
23. Maggard M.A., O'Connell J.B., Lane K.E., Liu J.H., Etzioni D.A., and Ko C.Y. Do young breast cancer patients have worse outcomes?. J. Surg. Res. 113 (2003) 109-113
24. Matthews R.H., Mc Neese M.D., Montague E.D., and Oswald M.J. Prognostic complications of age in breast cancer patients treated with tumorectomy and irradiation or with mastectomy. Int. J. Radiat. Oncol. Biol. Phys. 14 (1988) 659-663
25. Poortmans P.M. Radiothérapie prophylactique des aires ganglionnaires dans le cancer du sein. Cancer Radiother. 10 (2006) 343-348
26. Prowell T.M., and Davidson N.E. What is the role of ovarian ablation in the management of primary and metastatic breast cancer today?. Oncologist 9 (2004) 507-517
27. Xiong Q., Valero V., Kau V., Kau S.W., Taylor S., Smith T.L., et al. Female patients with breast carcinoma age 30 years and younger have a poor prognosis. The MD Anderson cancer center experience. Cancer 92 (2001) 2523-2528
28. Ribeiro G.G., and Swindell R. The prognosis of breast carcinoma in women aged less than 40 years. Clin. Radiol. 32 (1981) 231-236
29. Rochefordiere A., Asselain B., Campana F., Scholl S.M., Fenton J., Vilcoq J.R., et al. Age as prognosis factor in premenopausal breast carcinoma. Lancet 341 (1993) 1039-1043
30. Sidoni A., Cavaliere A., Bellezza G., Scheibel M., and Bucciarelli E. Breast cancer in young women, clinico pathological features and biological specificity. Breast 12 (2003) 247-250
31. Tuma R.S. Trastuzumab trials steal show at ASCO meeting. J. Natl. Cancer Inst. 97 (2005) 870-871